Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Ethicon Endo-Surgery snaps up SterilMed

You may also be interested in...



CMS Issues List Of Potential National Coverage Determination Topics

Most of the 33 items or services in the list have implications for manufacturers of medical devices, combination products or diagnostics.

Research In Brief

Recent data addressing transradial angioplasty, Medtronic’s new transcatheter aortic heart valve and more.

FDA Opens Device Criminal Investigations Under Pilot Program In 2011

Despite the name, FDA’s “Pharmaceutical Fraud Pilot Program” includes devices in its mission. Of the 16 criminal investigations opened under the program last year, two are explicitly focused on device companies.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030592

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel